MCRF 2018 GRANT
Dr. Brock Humphries earned his B.S. in Biology at Saginaw Valley State University, and his PhD in Cellular and Molecular Biology from Michigan State University. He is currently a postdoctoral research fellow in the Department of Radiology at the University of Michigan. His research uses a multidisciplinary approach to identify the molecular mechanisms that drive tumor recurrence and metastasis, with the goal of elucidating novel therapeutic targets for breast cancer. Please click on the following link for a description of Dr. Humphries' research.
MCRF 2017 GRANTS
Dr. Kaitlin Basham received her PhD in Oncology Sciences at the University of Utah, and completed her B.S. in Biology with a Psychology minor at Saint Mary's College of California. She is currently a postdoctoral fellow in the Department of Internal Medicine at the University of Michigan. Dr. Basham's research is aimed at determining how the loss of the ZNFR3/RNF43 genes disrupts equilibrium needed for normal cellular pathways function, and testing the efficacy of newly developed drugs to target tumors lacking these genes. Please click on the following link for a description of Dr. Basham's research.
Dr. Jennifer Speth received her PhD in Microbiology and Immunology at Indiana University after completing her bachelor of Science in Microbiology at Ball State University in Muncie, Indiana. She is currently a Postdoctoral Translational Scholar Program fellow at the University of Michigan’s Department of Internal Medicine - Pulmonary and Critical Care Division. Dr. Speth’s research focuses on exploring use of a novel type of cell to cell communication as a strategy to inhibit tumor formation and progression in lung cancer. Please click on the following link for a description of Dr. Speth’s research.
MCRF 2016 GRANTS
Daryl Staveness, PhD, received his B.S. in Chemistry at the University of Wisconsin-Madison, and his PhD in Organic Chemistry from Stanford University. Dr. Staveness is currently a postdoctoral researcher at the University of Michigan, where he is working to develop and evaluate a new building block for medicinal chemistry that will allow for the preparation of safer drugs. These efforts are a step toward reverting the stigma associated with the term “chemotherapy” into a more positive connotation that reflects the life-saving benefits of well-designed and appropriately-administered treatments. Please click on the following link for a description of Dr. Staveness' research.
Rochelle Tiedemann, PhD, graduated from the University of North Georgia with a B.S. in Biology, and received her PhD from Agusta University. Dr. Tiedemann's studies at the Van Andel Research Institute in Grand Rapids, MI, will use a recently developed model system of prostate cancer progression to characterize the dynamics of epigenome reprogramming in this disease. The results of this work will help identify epigenetic mechanisms that contribute to prostate cancer and will suggest new avenues of pursuit for therapeutic interventions to correct aberrant gene regulation in this disease. Please click on the following link for a description of Dr. Tiedemann's research.
Hilary Marusak, PhD, earned her B.A. in Biology and Psychology at Kalamazoo College, and received her PhD in Translational Neuroscience from Wayne State University School of Medicine in 2016. Her long-term goals for her research project at Wayne State concern the underpinnings of emotion (dys)regulation. Her focus is on furthering understanding of principles of brain organization against a backdrop of neurodevelopment, and how the trajectory of brain maturation may be altered as a function of risk or emerging psychopathology. Please click on the following link for a description of Hilary Marusak's research project which is focused on identifying neurobehavioral correlates of learning and memory in young cancer survivors.